Thursday 23 July saw senior leaders join the virtual launch of The AHSN Network report: Genomic Innovation: technologies for personalised medicine.
The virtual launch was led and hosted by The AHSN Network and chaired by Niall Dickson, Chief Executive of NHS Confederation.
Earlier in 2020 The AHSN Network commissioned the PHG Foundation to produce a report that presents an evidence review of genomics and genomics-related technologies that will have an impact on the delivery of personalised medicine within two to three years or even sooner given the current pace of change arising from the COVID-19 pandemic. The report builds on the 2018 PHG Foundation publication ‘The Personalised Medicine Technology Landscape’ from Professor Dame Sue Hill, Chief Scientific Officer and SRO for Genomics, NHS England, and underpins The AHSN Networks work in delivering a thematic programme on personalised medicine, established to support the implementation of novel diagnostic and treatment approaches that make use of genomics and other ‘omics technologies.
This new report focuses on five diagnostic and treatment areas;
- ctDNA testing
- Testing to support antimicrobial stewardship
- Genetically modified regenerative medicines.